(redirected from Glycopeptide antibiotic)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
See: drug
References in periodicals archive ?
Until the identification of the isolate described in this report, MRSA had been susceptible to vancomycin, a glycopeptide antibiotic introduced clinically in 1958.
The glycopeptide antibiotic vancomycin was first released in 1958, as the drug of choice for MRSA.
Infections caused by MRSA isolates are treated by Vancomycin (glycopeptide antibiotic) routinely.
An electronmicroscopic study of glycopeptide antibiotic resistant strains of Staphylococcus epidermidis.
Vancomycin, a glycopeptide antibiotic, was relied upon until recently to eradicate MRSA infection.
It is a glycopeptide antibiotic extracted from Actinoplanes teichomyceticus with a similar spectrum of activity to vancomycin.
The woodmice and bank voles may have been exposed in the woodland to either avoparcin (a glycopeptide antibiotic related to vancomycin) or fecal material from farm animals; however, avoparcin had not been used for any livestock raised in proximity to the sites, and the samples (including the badger samples) were taken after the use of avoparcin as a growth promoter had been banned.
Vancomycin is a glycopeptide antibiotic which acts by blocking the biosynthesis of bacterial cell wall.
INTRODUCTION: Vancomycin, a tricyclic glycopeptide antibiotic (C66H75C12N9024) first isolated from a soil bacterium Actinobacteria species Amycolatopsis orientalis, acts by inhibiting the formation of the peptidoglycan polymers of the bacterial cell wall.